Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -9.78% lower on its value in year-to-date trading and has touched a low of $5.26 and a high of $64.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $9.78 in the last trading session, with the day’s loss setting it -0.92%.
Currently trading at $8.86, the stock is -10.84% and -1.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing -9.41% at the moment leaves the stock -45.21% off its SMA200. DNA registered -84.29% loss for a year compared to 6-month loss of -23.12%. The firm has a 50-day simple moving average (SMA 50) of $9.0162 and a 200-day simple moving average (SMA200) of $16.3422.
The stock witnessed a -19.67% gain in the last 1 month and extending the period to 3 months gives it a 23.40%, and is -23.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.68% over the week and 11.79% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 1218 employees, a market worth around $509.26M and $217.95M in sales. Profit margin for the company is -298.78%. Distance from 52-week low is 68.44% and -86.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.37%).
with sales reaching $44.43M over the same period.The EPS is expected to grow by 45.22% this year, but quarterly earnings will post -9.45% year-over-year. Quarterly sales are estimated to grow 27.83% in year-over-year returns.
Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders
225.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 73.17% of the company’s shares. The shares outstanding are 41.37M, and float is at 36.49M with Short Float at 20.21%. Institutions hold 68.29% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 7.1383% of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.9327 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.7063% and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.485 of the shares totaling 69.85 million with a market value of $23.35 million.
Ginkgo Bioworks Holdings Inc (DNA) Insider Activity
#####
Still, SEC filings show that on Jan 06 ’25, Coen Steven P. disposed off 324 shares at an average price of $11.72 for $3797.0. The insider now directly holds 7,288 shares of Ginkgo Bioworks Holdings Inc (DNA).
